Company Performance: Revenue growth, profitability, and new product developments directly impact investor confidence and stock valuation.

Market Sentiment: Overall market conditions, investor psychology, and economic outlook can drive buying or selling pressure, affecting stock prices.

Industry Trends: Developments in the cannabis and pharmaceutical sectors, including regulatory changes and competitor activities, influence investor perception of CRBP2.PA.

Regulatory Environment: Changes in cannabis legalization, drug approvals, and healthcare policies can significantly alter the company's prospects and stock price.

Financial Health: Strong balance sheet, cash flow, and debt levels provide stability and attract investors, impacting stock valuation.

Global Economy: Macroeconomic factors such as interest rates, inflation, and currency fluctuations affect investor risk appetite and stock prices.

News and Events: Company-specific news, clinical trial results, mergers, acquisitions, and partnerships can cause rapid price fluctuations.

Investor Confidence: Investor beliefs in the company's management, strategy, and long-term growth potential drive demand and stock price.

Competition: The competitive landscape, including the presence of rival companies and alternative treatments, can impact market share and profitability.

Technological Advancements: Breakthroughs in cannabis research, drug delivery systems, and manufacturing processes can influence investor enthusiasm.

Supply and Demand: The basic principle of supply and demand in the stock market affects price. Higher demand leads to increased price, while higher supply leads to price decrease.

Geopolitical Factors: Political instability, trade wars, or social unrest in regions where the company operates or sells its products can introduce risk.

Currency Exchange Rates: Since CRBP2.PA is traded in Europe, currency fluctuations between the Euro and other currencies can impact investor returns.

Risk Tolerance: Investor risk appetite and tolerance affect the perceived value of the stock and thus its price.

Analyst Ratings: Opinions from financial analysts on the stock, including ratings upgrades or downgrades, can influence buying or selling decisions.